@article{2a34ba45d65a4989b856a6fc80eabaa2,
title = "Liver transplant induction trial of daclizumab to spare calcineurin inhibition",
keywords = "calcineurin inhibitor, creatinine, interleukin 2 receptor antibody, mycophenolic acid 2 morpholinoethyl ester, steroid, tacrolimus, calcineurin, daclizumab, immunoglobulin G, immunosuppressive agent, monoclonal antibody, adult, clinical trial, conference paper, controlled clinical trial, controlled study, creatinine blood level, drug efficacy, drug safety, drug withdrawal, graft rejection, hepatitis C, hospital admission, hospital cost, human, human tissue, kidney disease, kidney function, length of stay, liver biopsy, liver transplantation, major clinical study, priority journal, randomized controlled trial, recurrent disease, survival rate, treatment outcome, age, article, child, comparative study, drug antagonism, immunology, middle aged, mortality, physiology, postoperative complication, Age Factors, Antibodies, Monoclonal, Immunosuppressive Agents, Middle Age, Postoperative Complications, Recurrence, Humans",
author = "Thomas Heffron and Gregory Smallwood and Todd Pillen and Laurel Davis and Enrique Martinez and Rene Romero and Stieber, \{A. C.\}",
year = "2002",
month = jan,
day = "1",
language = "American English",
volume = "34",
journal = "PCOM Scholarly Works",
number = "5",
}